Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease (Q24613855)

3

object named as

Jonathan Himmelfarb

0 references

author name string

Rosemary Ouseph

2

0 references

M Elizabeth McMenamin

4

0 references

Richard A Ward

Clinical Journal of the American Society of Nephrology

5

0 references

language of work or name

English

0 references

publication date

September 2010

0 references

published in

0 references

volume

5

0 references

issue

9

0 references

page(s)

1588-94

0 references

cites work

The relationship between dose of vitamin E and suppression of oxidative stress in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

ESRD impairs nonrenal clearance of fexofenadine but not midazolam

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with fluorescence detection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Emerging evidence of the impact of kidney disease on drug metabolism and transport

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Assessing kidney function--measured and estimated glomerular filtration rate

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

N-acetylcysteine: pharmacological considerations and experimental and clinical applications.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Pharmacokinetics of N-acetylcysteine in man.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Clinical pharmacokinetics of N-acetylcysteine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Alterations of the Cl-/NaCO3- anion exchanger in erythrocytes of uraemic patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Effects of oral N-acetylcysteine on plasma homocysteine and whole blood glutathione levels in healthy, non-pregnant women

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and S-alkyl-N-acetyl-L-cysteines.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974398

Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

N -Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020

Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20538838

12 December 2020